We should be measuring genomic bacterial load and virulence factors

被引:27
作者
Lisboa, Thiago [2 ]
Waterer, Grant [3 ]
Rello, Jordi [1 ]
机构
[1] Univ Autonoma Barcelona, Crit Care Dept, Hosp Vall dHebron, Fundacio Inst Recerca, E-08193 Barcelona, Spain
[2] Hosp Clin Porto Alegre, Crit Care Dept, Porto Alegre, RS, Brazil
[3] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia
关键词
genomic bacterial load; virulence; pathogenesis; sepsis; infection; pathogen; POLYMERASE-CHAIN-REACTION; VENTILATOR-ASSOCIATED PNEUMONIA; PSEUDOMONAS-AERUGINOSA PNEUMONIA; BLOOD-STREAM INFECTIONS; III PROTEIN SECRETION; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; MENINGOCOCCAL DISEASE; HUMAN NEUTROPHILS; CYSTIC-FIBROSIS;
D O I
10.1097/CCM.0b013e3181f2453a
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To describe relevant pathogen-related characteristics and their impact on sepsis pathogenesis and prognosis. Data Source: Current literature regarding genomic bacterial load and virulence factors, with an emphasis on the impact of these factors on pathophysiology and prognosis of sepsis. Data Extraction and Synthesis: The current paradigm on sepsis pathophysiology and management overlooks aspects concerning the nature and characteristics of the infecting pathogen. Our findings suggest that evaluation of genomic bacterial load might be useful to assess severity and predict prognosis in septic patients; its use during treatment for monitoring clinical response is another interesting potential application. Virulence factors identification might help to develop pathogen-specific therapeutic strategies for higher-risk septic patients. Conclusions: The recognition of the importance of quantifying the pathogen has major clinical implications and will open up a new field of exploration of therapies targeted at anticipating development and appropriate treatment in severe sepsis. The improved detection and understanding of bacterial virulence factors may lead to specific therapies. (Crit Care Med 2010; 38[Suppl.]:S656-S662)
引用
收藏
页码:S656 / S662
页数:7
相关论文
共 66 条
[1]   Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro [J].
Anderson, R. ;
Steel, H. C. ;
Cockeran, R. ;
Von Gottberg, A. ;
de Gouveia, L. ;
Klugman, K. P. ;
Mitchell, T. J. ;
Feldman, C. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (05) :1155-1158
[2]   Community-acquired bacteria frequently detected by means of quantitative polymerase chain reaction in nosocomial early-onset ventilator-associated pneumonia [J].
Apfalter, P ;
Stoiser, B ;
Barousch, W ;
Nehr, M ;
Kramer, L ;
Burgmann, H .
CRITICAL CARE MEDICINE, 2005, 33 (07) :1492-1498
[3]   Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].
Bauer, S ;
Kirschning, CJ ;
Häcker, H ;
Redecke, V ;
Hausmann, S ;
Akira, S ;
Wagner, H ;
Lipford, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242
[4]  
BELL LM, 1985, PEDIATRICS, V76, P901
[5]   Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins [J].
Berry, AM ;
Paton, JC .
INFECTION AND IMMUNITY, 2000, 68 (01) :133-140
[6]   Plasma interferon-γ and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock [J].
Bjerre, A ;
Brusletto, B ;
Hoiby, EA ;
Kierulf, P ;
Brandtzaeg, P .
CRITICAL CARE MEDICINE, 2004, 32 (02) :433-438
[7]   A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis [J].
Bloos, Frank ;
Hinder, Frank ;
Becker, Karsten ;
Sachse, Svea ;
Dessap, Armand Mekontso ;
Straube, Eberhard ;
Cattoir, Vincent ;
Brun-Buisson, Christian ;
Reinhart, Konrad ;
Peters, Georg ;
Bauer, Michael .
INTENSIVE CARE MEDICINE, 2010, 36 (02) :241-247
[8]   The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation [J].
Brandtzaeg, P ;
Hogasen, K ;
Kierulf, P ;
Mollnes, TE .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03) :647-655
[9]   Neisseria meningitidis lipopolysaccharides in human pathology [J].
Brandtzaeg, P ;
Bjerre, A ;
Ovstebo, R ;
Brusletto, B ;
Joo, GB ;
Kierulf, P .
JOURNAL OF ENDOTOXIN RESEARCH, 2001, 7 (06) :401-420
[10]  
BRANDTZAEG P, 2001, MENINGOCOCCAL DIS ME, P411